农药

Search documents
利民股份:2025年8月公司正式签署巴西代森锰锌登记证收购协议
Zheng Quan Ri Bao Zhi Sheng· 2025-08-26 11:16
(编辑 袁冠琳) 证券日报网讯 利民股份8月26日在互动平台回答投资者提问时表示,2025年8月,公司正式签署巴西代 森锰锌(Mancozeb)登记证(涵盖原药及80%WP制剂)的收购协议,为公司进一步深耕拉美市场奠定 了坚实基础。 ...
基础化工行业周报:韩国或将削减石脑油产能,草甘膦价格再度上涨-20250826
Donghai Securities· 2025-08-26 11:07
Investment Rating - The report rates the industry as "Overweight" [1] Core Viewpoints - Supply-side structural optimization is expected, with a focus on selecting elastic and advantageous sectors. Domestic policies frequently mention supply-side requirements, while rising raw material costs and capacity shocks in Asia have led to shutdowns and capacity exits among European and American chemical companies. In the short term, geopolitical tensions increase uncertainty in overseas chemical supply, but in the long term, China's chemical industry chain has a clear competitive advantage, rapidly filling gaps in the international supply chain and potentially reshaping the global chemical industry landscape [4][14] Summary by Sections Industry News and Events - South Korea plans to cut 25% of its naphtha cracking capacity, shifting towards higher value-added products. This restructuring involves reducing excess capacity and improving financial health while minimizing economic and employment impacts. The government will support proactive industry measures with relaxed regulations and fiscal policies [5][12] - Glyphosate prices are rising again, with domestic factory inventory significantly decreasing. As of August 24, 2025, the inventory was 27,800 tons, down 60.34% year-on-year and 2.46% month-on-month. The market anticipates a slight price increase due to strong domestic demand and export orders [6][13] Chemical Sector Performance - For the week of August 18-22, 2025, the CSI 300 index rose by 4.18%, while the Shenwan Oil and Petrochemical Index increased by 2.92%, underperforming the market by 1.26 percentage points. The Shenwan Basic Chemical Index rose by 2.86%, also underperforming the market by 1.32 percentage points [16][17] - The top five performing sub-sectors included Other Rubber Products (8.53%), Polyurethane (6.34%), Titanium Dioxide (5.69%), Other Petrochemicals (5.05%), and Fluorochemicals (4.79%) [17] Key Product Price Trends - The top price increases for the week included Light Soda Ash (8.25%), Soft Foam Polyether (6.04%), Heavy Soda Ash (5.97%), TDI (4.99%), and Caustic Soda (4.50%). Conversely, the largest price drops were seen in Polytetrafluoroethylene (-26.19%), Methyl Acrylate (-7.16%), and Vitamin E (-7.14%) [27][28] - The price spread for key products showed significant increases for products like Adipic Acid-Pure Benzene (16.78%) and Propylene Oxide-0.8*Propylene (15.60%) [30][31] Investment Recommendations - Focus on sectors with significant supply-side reform potential, such as organic silicon, membrane materials, chlorine-alkali, and dyes. Key companies to watch include Hoshine Silicon Industry, Xingfa Group, and Zhejiang Longsheng [4][14] - In the agricultural chemicals sector, companies like Yangnong Chemical and Guangxin Co. are highlighted for their relative advantages [14][15]
新农股份:8月26日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-26 10:48
每经AI快讯,新农股份(SZ 002942,收盘价:19.55元)8月26日晚间发布公告称,公司第七届第二次 董事会会议于2025年8月26日在公司会议室以现场结合通讯方式召开。会议审议了《2025年半年度募集 资金存放与使用情况专项报告》等文件。 每经头条(nbdtoutiao)——能给主人"打电话"的宠物智能手机也来了!宠物产业3000亿元市场大爆 发,行业上市公司"涨"声一片 (记者 王晓波) 截至发稿,新农股份市值为30亿元。 2025年1至6月份,新农股份的营业收入构成为:农药行业占比93.18%,其他业务占比6.82%。 ...
美邦股份: 陕西美邦药业集团股份有限公司2025年第一次临时股东会通知
Zheng Quan Zhi Xing· 2025-08-26 09:22
证券代码:605033 证券简称:美邦股份 公告编号:2025-047 陕西美邦药业集团股份有限公司 关于召开2025年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: (三)投票方式:本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 召开的日期时间:2025 年 9 月 26 日 15 点 00 分 召开地点:陕西省西安市经济技术开发区草滩三路石羊工业园区 A19 号楼陕 西美邦药业集团股份有限公司三楼会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东大会网络投票系统 网络投票起止时间:自2025 年 9 月 26 日 至2025 年 9 月 26 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段,即 9:15-9:25,9:30-11:30,13:00-15:00;通过互 联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 序号 议案名称 东 ...
美邦股份: 陕西美邦药业集团股份有限公司关于2025年半年度募集资金存放与实际使用情况的专项报告的公告
Zheng Quan Zhi Xing· 2025-08-26 09:17
| 证券代码:605033 证券简称:美邦股份 公告编号:2025-045 | | | | | --- | --- | --- | --- | | 陕西美邦药业集团股份有限公司 | | | | | 2025 年半年度募集资金存放与实际使用情况的 | | | 关于 | | 专项报告的公告 | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 | | | | | 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 | | | | | 根据中国证券监督管理委员会《上市公司募集资金监管规则》以及《上海证 | | | | | 券交易所上市公司自律监管指引第1号——规范运作》《上海证券交易所股票上 | | | | | 市规则》等有关规定,将陕西美邦药业集团股份有限公司(以下简称本公司、公 | | | | | 司或美邦股份)2025年半年度募集资金存放与使用情况报告如下: | | | | | 一、募集资金基本情况 | | | | | (一)实际募集资金金额、资金到位情况 | | | | | 经中国证券监督管理委员会《关于核准陕西美邦药业集团股份有限公司首次 | | | | ...
美邦股份: 陕西美邦药业集团股份有限公司2025年上半年度主要经营数据公告
Zheng Quan Zhi Xing· 2025-08-26 09:17
Core Viewpoint - The announcement provides an overview of the operational performance of Shaanxi Meibang Pharmaceutical Group Co., Ltd. for the first half of 2025, detailing production, sales, and revenue figures for its main products, as well as price changes for both products and raw materials [1]. Group 1: Main Products Performance - The production volume for fungicides was 3,033.70 tons, with sales of 3,188.00 tons, generating revenue of 252.60 million yuan [1]. - The production volume for insecticides was 1,677.17 tons, with sales of 2,029.64 tons, generating revenue of 161.27 million yuan [1]. - Other products had a production volume of 1,282.02 tons, with sales of 1,214.48 tons, generating revenue of 68.80 million yuan [1]. Group 2: Price Changes of Main Products - The average selling price of fungicides decreased from 87,652.39 yuan/ton to 79,235.29 yuan/ton, a change of -9.60% [1]. - The average selling price of insecticides decreased from 83,721.80 yuan/ton to 79,455.81 yuan/ton, a change of -5.10% [1]. - The average selling price of other products remained relatively stable, changing from 56,649.18 yuan/ton to 56,653.30 yuan/ton, a change of 0.01% [1]. Group 3: Price Changes of Raw Materials - The price of benzimidazole decreased from 8.91 million yuan/ton to 8.47 million yuan/ton, a change of -4.98% [1]. - The price of pyrazole decreased from 15.19 million yuan/ton to 14.22 million yuan/ton, a change of -6.36% [1]. - The price of flubendiamide decreased significantly from 30.02 million yuan/ton to 24.65 million yuan/ton, a change of -17.89% [1]. - The price of methomyl increased from 46.33 million yuan/ton to 62.47 million yuan/ton, a change of 34.84% [1]. - The price of methyl thiophanate decreased from 3.39 million yuan/ton to 2.98 million yuan/ton, a change of -12.16% [1].
美邦股份(605033) - 陕西美邦药业集团股份有限公司2025年上半年度主要经营数据公告
2025-08-26 09:12
主要产品 2025 年 1-6 月产量 (吨) 2025 年 1-6 月销量 (吨) 2025 年 1-6 月销售 金额(万元) 杀菌剂 3,033.70 3,188.00 25,260.21 杀虫剂 1,677.17 2,029.64 16,126.67 其它 1,282.02 1,214.48 6,880.43 一、主要产品的产量、销量及收入实现情况(不含税) 三、主要原材料的价格变动情况(不含税) | 主要原材料 | 2025 年 1-6 月平均 进价(万元/吨) | 2024 年 1-6 月平均 进价(万元/吨) | 变动比率(%) | | --- | --- | --- | --- | | 苯醚甲环唑 | 8.47 | 8.91 | -4.98 | | 吡唑醚菌酯 | 14.22 | 15.19 | -6.36 | | 氟啶虫酰胺 | 24.65 | 30.02 | -17.89 | | 甲维盐 | 62.47 | 46.33 | 34.84 | | 甲基硫菌灵 | 2.98 | 3.39 | -12.16 | 证券代码:605033 证券简称:美邦股份 公告编号:2025-042 陕西美邦药业集团 ...
美邦股份:上半年归母净利润3613.73万元,同比下降23.81%
Xin Lang Cai Jing· 2025-08-26 09:06
美邦股份8月26日披露的半年报显示,公司上半年实现营业收入4.85亿元,同比下降4.76%;归属于上市 公司股东的净利润3613.73万元,同比下降23.81%;基本每股收益0.27元。 ...
生猪养殖行业“反内卷”政策密集发布,建信中证农牧主题ETF(159616)跟踪指数冲高上涨2.41%
Sou Hu Cai Jing· 2025-08-26 07:06
截至2025年8月26日 14:41,中证农牧主题指数(931778)上涨2.41%,样本股牧原股份(002714)上涨 7.51%,天康生物(002100)上涨6.04%,江山股份(600389)上涨5.74%,东方铁塔(002545),广信股份 (603599)等个股均上涨。 太平洋证券指出,生猪养殖行业反内卷调控政策近期密集发布,继发改委6月初提出了不增产能和降重 稳价倡议,以及农业部7月下旬召集养殖屠宰核心企业会议提出了严格落实产能调控举措之后,行业协 会8月13日召开会议倡议行业削减产能至3950万头,多家头部企业参会。会后业内龙头企业积极响应产 能调控政策,表态将削减能繁母猪存栏量。尽管育肥和扩繁环节持续盈利,但预计随着反内卷政策的继 续实施和规避疫情风险的影响,行业产能有望去化。 建信中证农牧主题ETF(159616)紧密跟踪中证农牧主题指数,中证农牧主题指数选取50只业务涉及粮食 种植、种子生产、农药化肥、农用机械、畜牧养殖、饲料生产以及动物保健等相关领域的上市公司证券 作为样本,以反映农牧主题上市公司证券的整体表现。 以上内容与数据,与有连云立场无关,不构成投资建议。据此操作,风险自担。 近 ...
扬农化工(600486):原药市场触底回升,辽宁优创释放增量
Shanxi Securities· 2025-08-26 06:47
Investment Rating - The report maintains a "Buy-B" rating for the company [3][7]. Core Views - The original drug market is recovering, and the Liaoning Youchuang project is gradually releasing additional capacity [5]. - The company achieved a revenue of 6.234 billion yuan in H1 2025, a year-on-year increase of 9.38%, with a net profit of 806 million yuan, up 5.6% year-on-year [4]. - The company is expanding its market share in Southeast Asia, increasing from 5% to approximately 70% [5]. Financial Performance - For Q2 2025, the company reported a revenue of 2.993 billion yuan, with a year-on-year growth of 18.63% [4]. - The basic earnings per share (EPS) for the year ending June 30, 2025, is 2.00 yuan, with a net asset return rate of 7.24% [2]. - The projected net profits for 2025, 2026, and 2027 are 1.48 billion, 1.70 billion, and 1.97 billion yuan, respectively, with corresponding P/E ratios of 20, 17, and 15 times [7]. Market Dynamics - The original drug sales volume in Q2 2025 reached 28,037 tons, a year-on-year increase of 12%, primarily due to the capacity release from the Ning Youchuang project [5]. - The sales price of original drugs was 65,900 yuan per ton, reflecting a year-on-year increase of 3.2% [5]. - The insecticide market is recovering due to the demand for preventing diseases like Chikungunya and Dengue fever, with the company's products being favored for their efficiency and low toxicity [6].